Cite
HARVARD Citation
Proto, C. et al. (2019). Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out. Cancer treatment reviews. pp. 39-51. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Proto, C. et al. (2019). Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out. Cancer treatment reviews. pp. 39-51. [Online].